XML 16 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock Outstanding [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2019 8,924,988            
Balance at Dec. 31, 2019   $ 89 $ 15,450   $ (94) $ 21,844 $ 37,289
Net income           1,047 1,047
Stock compensation expense     62       62
Foreign currency translation adjustment         (31)   (31)
Balance (in shares) at Mar. 31, 2020 8,924,988            
Balance at Mar. 31, 2020   89 15,512   (125) 22,891 38,367
Balance (in shares) at Dec. 31, 2019 8,924,988            
Balance at Dec. 31, 2019   89 15,450   (94) 21,844 37,289
Net income             6,042
Balance (in shares) at Sep. 30, 2020 8,929,368            
Balance at Sep. 30, 2020   89 15,780   (129) 27,886 43,626
Balance (in shares) at Mar. 31, 2020 8,924,988            
Balance at Mar. 31, 2020   89 15,512   (125) 22,891 38,367
Net income           2,200 2,200
Stock compensation expense     61       61
Foreign currency translation adjustment         (15)   (15)
Balance (in shares) at Jun. 30, 2020 8,924,988            
Balance at Jun. 30, 2020   89 15,573   (140) 25,091 40,613
Net income           2,795 2,795
Stock compensation expense     207       207
Foreign currency translation adjustment         11   11
Balance (in shares) at Sep. 30, 2020 8,929,368            
Balance at Sep. 30, 2020   89 15,780   (129) 27,886 43,626
Balance (in shares) at Dec. 31, 2020 8,885,797            
Balance at Dec. 31, 2020   89 15,836 $ (1,639) (140) 30,005 44,151
Net income           1,040 1,040
Stock compensation expense     57       57
Foreign currency translation adjustment         4   4
Common stock repurchased* (in shares) [1] (70,947)            
Common stock repurchased* [1]       (2,712)     (2,712)
Stock options exercised (in shares) 67,500            
Stock options exercised   1 106       107
Balance (in shares) at Mar. 31, 2021 8,882,350            
Balance at Mar. 31, 2021   90 15,999 (4,351) (136) 31,045 42,647
Balance (in shares) at Dec. 31, 2020 8,885,797            
Balance at Dec. 31, 2020   89 15,836 (1,639) (140) 30,005 44,151
Net income             $ 6,379
Stock options exercised (in shares)             67,500
Balance (in shares) at Sep. 30, 2021 8,700,569            
Balance at Sep. 30, 2021   90 16,229 (10,900) (145) 36,384 $ 41,658
Balance (in shares) at Mar. 31, 2021 8,882,350            
Balance at Mar. 31, 2021   90 15,999 (4,351) (136) 31,045 42,647
Net income           2,805 2,805
Stock compensation expense     198       198
Foreign currency translation adjustment         4   4
Common stock repurchased* (in shares) [1] (144,194)            
Common stock repurchased* [1]       (5,048)     (5,048)
Stock compensation expense (in shares) 4,443            
Balance (in shares) at Jun. 30, 2021 8,742,599            
Balance at Jun. 30, 2021   90 16,197 (9,399) (132) 33,850 40,606
Net income           2,534 2,534
Stock compensation expense     32       32
Foreign currency translation adjustment         (13)   (13)
Common stock repurchased* (in shares) [1] (42,030)            
Common stock repurchased* [1]       (1,501)     $ (1,501)
Stock options exercised (in shares)             0
Balance (in shares) at Sep. 30, 2021 8,700,569            
Balance at Sep. 30, 2021   $ 90 $ 16,229 $ (10,900) $ (145) $ 36,384 $ 41,658
[1] At September 30, 2021, approximately $4,100,000 was authorized for future repurchases of our common stock.